|
|
 |
|
Viewing report
|
|
|
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline
GlobalData, March 2011, Pages: 5
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline
Summary
GlobalData’s report, “Iniparib Failure - Highlights the Uncertainty in Late Stage Breast Cancer Pipeline” provides key information on current available treatment of Alzheimer's disease, drivers and barriers for the future market and how the novel pipeline molecules will drive the global market
Scope
- Data and information on the failure of Iniparib in late stage breast cancer pipeline
Reasons to buy
- Develop business strategies by understanding the trends and developments in breast cancer market
|
|
|
|
